Hidden in Plain Sight: Identifying Women Living in the United States Who Could Benefit From HIV Preexposure Prophylaxis

HIV preexposure prophylaxis (PrEP) with oral tenofovir/emtricitabine is an effective means of decreasing human immunodeficiency virus (HIV) acquisition among women. However, few women are prescribed and are taking PrEP. This article offers perspectives on barriers to use and strategies to increase u...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 2020-10, Vol.222 (9), p.1428-1431
Main Authors: Ojikutu, B O, Mayer, K H
Format: Article
Language:English
Subjects:
Adult
Anti-HIV Agents - therapeutic use
Editor's Choice
Female
HIV Infections - prevention & control
Humans
Pre-Exposure Prophylaxis
Risk Factors
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:HIV preexposure prophylaxis (PrEP) with oral tenofovir/emtricitabine is an effective means of decreasing human immunodeficiency virus (HIV) acquisition among women. However, few women are prescribed and are taking PrEP. This article offers perspectives on barriers to use and strategies to increase uptake among women.
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/jiz416